These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 6396359)
21. Postmenopausal osteoporosis. Pathogenesis and the modeof action of hormone therapy. Holló I Ther Hung; 1972; 20(4):123-6 passim. PubMed ID: 4679500 [No Abstract] [Full Text] [Related]
22. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. North American Menopause Society. Menopause; 2002; 9(2):84-101. PubMed ID: 11875327 [TBL] [Abstract][Full Text] [Related]
23. [Recent diagnostic and therapeutic findings on postmenopausal and senile osteoporosis]. Isaia GC; Salamano G; Molinatti GM Minerva Med; 1988 May; 79(5):327-42. PubMed ID: 3287224 [TBL] [Abstract][Full Text] [Related]
24. [Osteoporosis therapy, current status]. Felder M; Dambacher MA Schweiz Rundsch Med Prax; 1994 Jan; 83(3):84-6. PubMed ID: 8296136 [TBL] [Abstract][Full Text] [Related]
26. Current and future nonhormonal approaches to the treatment of osteoporosis. Bilezikian JP Int J Fertil Menopausal Stud; 1996; 41(2):148-55. PubMed ID: 8829694 [TBL] [Abstract][Full Text] [Related]
27. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
28. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens]. Nocke W Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382 [TBL] [Abstract][Full Text] [Related]
29. The treatment of osteoporosis. Antiresorptive therapy. Miller PD Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624 [TBL] [Abstract][Full Text] [Related]
30. Menopause--a medical challenge. Yen SC West J Med; 1982 Mar; 136(3):242-4. PubMed ID: 7090373 [No Abstract] [Full Text] [Related]
31. Osteoporosis: regulatory view. Sobel S Public Health Rep; 1987; 102(4 Suppl):136-9. PubMed ID: 3120212 [TBL] [Abstract][Full Text] [Related]
32. Studies on osteoporoses. XI. Effects of a methylxanthine derivative. A preliminary report. Robin JC; Ambrus JL J Med; 1983; 14(2):137-45. PubMed ID: 6310016 [TBL] [Abstract][Full Text] [Related]
33. Studies on osteoporosis. IX. Effect of fluoride on steroid induced osteoporosis. Robin JC; Ambrus JL Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):453-61. PubMed ID: 7178655 [TBL] [Abstract][Full Text] [Related]
34. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of osteoporosis. Review of recent literature]. Gretzmacher-Becker I Fortschr Med; 1983 Apr; 101(16):743-5. PubMed ID: 6852749 [TBL] [Abstract][Full Text] [Related]
36. Anabolic steroids in corticosteroid-induced osteoporosis. Adami S; Rossini M Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of osteoporosis: current data and prospects]. Reginster JY; Deroisy R; Franchimont P Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):155S-164S. PubMed ID: 7858567 [TBL] [Abstract][Full Text] [Related]
38. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related]
39. Drugs for postmenopausal osteoporosis. Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621 [No Abstract] [Full Text] [Related]